Drug DrugBank | All Description Patterns💬 Info on mouse-over
No. | Drug (Description in trials) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY On map, Yellow: Drug target genes |
Disease ID |
1 | Alx-0081 | - | - | - | - | 064 [1] 64 💬 |
2 | Caplacizumab (alx-0081) | Caplacizumab | [1] D11160 D11160 💬 |
VWF [1] VWF 💬 |
Complement and coagulation cascades [8] Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation |
064 [1] 64 💬 |
3 | Caplacizumab (an anti-von willebrand factor nanobody alx-0081) | Caplacizumab | [1] D11160 D11160 💬 |
VWF [1] VWF 💬 |
Complement and coagulation cascades [8] Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation |
064 [1] 64 💬 |